Combined treatment with biphosphonates, low-dose chemotherapy, and trastuzumab in receptor-negative breast cancer patients with bone marrow involvement

By Bezares S.   Amador M.L.   Castellano D.   Trigo J.M.   Cortes-Funes H.   Colomer R.  

European Journal of Internal Medicine, Vol. 12, Iss. 5, 2001-09 ,pp. : 462-463

Elsevier

Access to resources Recommend Favorite

Fecal Occult Blood Test in Patients on Low-Dose Aspirin, Warfarin, Clopidogrel, or Non-steroidal Anti-inflammatory Drugs

By Sawhney Mandeep   McDougall Heather   Nelson Douglas   Bond John  

Digestive Diseases and Sciences, Vol. 55, Iss. 6, 2010-06 ,pp. : 1637-1642

Springer Publishing Company

Access to resources Recommend Favorite

Increased expression of vascular endothelial growth factor in bone marrow of multiple myeloma patients

By Wrobel T.   Mazur G.   Surowiak P.   Dziegiel P.   Usnarska-Zubkiewicz L.   Kuliczkowski K.  

European Journal of Internal Medicine, Vol. 14, Iss. 2, 2003-03 ,pp. : 98-100

Elsevier

Access to resources Recommend Favorite

Bone marrow megakaryocytes, soluble P-selectin and thrombopoietic cytokines in multiple myeloma patients

By Lemancewicz Dorota   Bolkun Lukasz   Mantur Maria   Semeniuk Janusz   Kloczko Janusz   Dzieciol Janusz  

Platelets, Vol. 25, Iss. 3, 2014-05 ,pp. : 181-187

Informa Healthcare

Access to resources Recommend Favorite

Myeloma Cells and Their Interactions With the Bone Marrow Endothelial Cells

By  

Current Immunology Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 41-55

Bentham Science Publishers

Access to resources Recommend Favorite